Haemonetics Corp (NYSE:HAE)
| 88.12 Delayed Data As of Jun 02 |  -0.01 / -0.01%Today’s Change | 58.23 Today|||52-Week Range 91.39 | +12.04% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $4.5B |
Company Description
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Contact Information
Haemonetics Corp. 125 Summer Street Boston Massachusetts 02110 |
Employees
Shareholders
| Mutual fund holders | 69.95% |
| Other institutional | 31.52% |
| Individual stakeholders | 3.14% |
Top Executives
| Christopher A. Simon | President, Chief Executive Officer & Director |
| James C. Darecca | Chief Financial Officer & Executive Vice President |
| Jan Hartmann | Senior Vice President & Chief Medical Officer |
| Anila Lingamneni | Chief Technology Officer & Executive VP |
| Laurie A. Miller | Chief Human Resources Officer & Senior VP |
